frequency
int64 1
472k
| HCPCS_Cd
stringlengths 5
5
| HCPCS_Desc
stringlengths 4
256
| rn
float64 1
1
|
|---|---|---|---|
1
|
L7520
|
Repair prosthetic device, labor component, per 15 minutes
| 1
|
34
|
L8606
|
Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies
| 1
|
7
|
L8607
|
Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies
| 1
|
1
|
L8615
|
Headset/headpiece for use with cochlear implant device, replacement
| 1
|
1
|
L8616
|
Microphone for use with cochlear implant device, replacement
| 1
|
3
|
L8618
|
Transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement
| 1
|
3
|
L8619
|
Cochlear implant, external speech processor and controller, integrated system, replacement
| 1
|
3
|
L8621
|
Zinc air battery for use with cochlear implant device and auditory osseointegrated sound processors, replacement, each
| 1
|
1
|
L8623
|
Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each
| 1
|
3
|
L8624
|
Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each
| 1
|
2
|
L8625
|
External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each
| 1
|
2
|
L8628
|
Cochlear implant, external controller component, replacement
| 1
|
1
|
L8629
|
Transmitting coil and cable, integrated, for use with cochlear implant device, replacement
| 1
|
1
|
L8642
|
Hallux implant
| 1
|
1
|
L8659
|
Interphalangeal finger joint replacement, 2 or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for surgical implantation, any size
| 1
|
14
|
L8679
|
Implantable neurostimulator, pulse generator, any type
| 1
|
4
|
L8681
|
Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only
| 1
|
6
|
L8683
|
Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver
| 1
|
3
|
L8689
|
External recharging system for battery (internal) for use with implantable neurostimulator, replacement only
| 1
|
2
|
L8691
|
Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each
| 1
|
2
|
L8694
|
Auditory osseointegrated device, transducer/actuator, replacement only, each
| 1
|
865
|
M0201
|
Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home
| 1
|
1
|
M0220
|
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise
| 1
|
221
|
M0239
|
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring
| 1
|
58
|
M0240
|
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses
| 1
|
13
|
M0241
|
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri
| 1
|
1,262
|
M0243
|
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring
| 1
|
132
|
M0244
|
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri
| 1
|
164
|
M0245
|
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring
| 1
|
25
|
M0246
|
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergen
| 1
|
48
|
M0247
|
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring
| 1
|
10
|
M0248
|
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
| 1
|
36
|
P9016
|
Red blood cells, leukocytes reduced, each unit
| 1
|
17
|
P9020
|
Platelet rich plasma, each unit
| 1
|
1
|
P9021
|
Red blood cells, each unit
| 1
|
1
|
P9037
|
Platelets, pheresis, leukocytes reduced, irradiated, each unit
| 1
|
4
|
P9040
|
Red blood cells, leukocytes reduced, irradiated, each unit
| 1
|
2
|
P9041
|
Infusion, albumin (human), 5%, 50 ml
| 1
|
1
|
P9043
|
Infusion, plasma protein fraction (human), 5%, 50 ml
| 1
|
1
|
P9045
|
Infusion, albumin (human), 5%, 250 ml
| 1
|
1
|
P9046
|
Infusion, albumin (human), 25%, 20 ml
| 1
|
21
|
P9047
|
Infusion, albumin (human), 25%, 50 ml
| 1
|
2
|
P9058
|
Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit
| 1
|
11
|
P9073
|
Platelets, pheresis, pathogen-reduced, each unit
| 1
|
1,372
|
Q0138
|
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
| 1
|
1
|
Q0220
|
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise
| 1
|
24
|
Q0239
|
Injection, bamlanivimab-xxxx, 700 mg
| 1
|
33
|
Q0240
|
Injection, casirivimab and imdevimab, 600 mg
| 1
|
58
|
Q0243
|
Injection, casirivimab and imdevimab, 2400 mg
| 1
|
139
|
Q0244
|
Injection, casirivimab and imdevimab, 1200 mg
| 1
|
29
|
Q0245
|
Injection, bamlanivimab and etesevimab, 2100 mg
| 1
|
12
|
Q0247
|
Injection, sotrovimab, 500 mg
| 1
|
2
|
Q0477
|
Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only
| 1
|
2
|
Q0479
|
Power module for use with electric or electric/pneumatic ventricular assist device, replacement only
| 1
|
3
|
Q0481
|
Microprocessor control unit for use with electric ventricular assist device, replacement only
| 1
|
2
|
Q0495
|
Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only
| 1
|
1
|
Q0496
|
Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
| 1
|
3
|
Q0497
|
Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only
| 1
|
2
|
Q0498
|
Holster for use with electric or electric/pneumatic ventricular assist device, replacement only
| 1
|
3
|
Q0501
|
Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
| 1
|
4
|
Q0506
|
Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
| 1
|
11
|
Q0508
|
Miscellaneous supply or accessory for use with an implanted ventricular assist device
| 1
|
7
|
Q0509
|
Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
| 1
|
11
|
Q3001
|
Radioelements for brachytherapy, any type, each
| 1
|
1,659
|
Q3014
|
Telehealth originating site facility fee
| 1
|
3
|
Q4005
|
Cast supplies, long arm cast, adult (11 years +), plaster
| 1
|
62
|
Q4021
|
Cast supplies, short arm splint, adult (11 years +), plaster
| 1
|
298
|
Q4022
|
Cast supplies, short arm splint, adult (11 years +), fiberglass
| 1
|
1
|
Q4041
|
Cast supplies, long leg splint, adult (11 years +), plaster
| 1
|
1
|
Q4042
|
Cast supplies, long leg splint, adult (11 years +), fiberglass
| 1
|
71
|
Q4046
|
Cast supplies, short leg splint, adult (11 years +), fiberglass
| 1
|
83
|
Q4049
|
Finger splint, static
| 1
|
9
|
Q4110
|
Primatrix, per square centimeter
| 1
|
7
|
Q4117
|
Hyalomatrix, per square centimeter
| 1
|
13
|
Q4121
|
Theraskin, per square centimeter
| 1
|
4
|
Q4124
|
Oasis ultra tri-layer wound matrix, per square centimeter
| 1
|
1
|
Q4127
|
Talymed, per square centimeter
| 1
|
1
|
Q4132
|
Grafix core and grafixpl core, per square centimeter
| 1
|
18
|
Q4133
|
Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter
| 1
|
1
|
Q4137
|
Amnioexcel, amnioexcel plus or biodexcel, per square centimeter
| 1
|
4
|
Q4145
|
Epifix, injectable, 1 mg
| 1
|
2
|
Q4148
|
Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter
| 1
|
1
|
Q4151
|
Amnioband or guardian, per square centimeter
| 1
|
25
|
Q4158
|
Kerecis omega3, per square centimeter
| 1
|
128
|
Q4159
|
Affinity, per square centimeter
| 1
|
8
|
Q4160
|
Nushield, per square centimeter
| 1
|
46
|
Q4162
|
Woundex flow, bioskin flow, 0.5 cc
| 1
|
1
|
Q4163
|
Woundex, bioskin, per square centimeter
| 1
|
32
|
Q4169
|
Artacent wound, per square centimeter
| 1
|
13
|
Q4171
|
Interfyl, 1 mg
| 1
|
37
|
Q4173
|
Palingen or palingen xplus, per square centimeter
| 1
|
18
|
Q4174
|
Palingen or promatrx, 0.36 mg per 0.25 cc
| 1
|
1
|
Q4176
|
Neopatch or therion, per square centimeter
| 1
|
183
|
Q4177
|
Floweramnioflo, 0.1 cc
| 1
|
39
|
Q4178
|
Floweramniopatch, per square centimeter
| 1
|
27
|
Q4180
|
Revita, per square centimeter
| 1
|
10
|
Q4185
|
Cellesta flowable amnion (25 mg per cc); per 0.5 cc
| 1
|
126
|
Q4186
|
Epifix, per square centimeter
| 1
|
10
|
Q4187
|
Epicord, per square centimeter
| 1
|
6
|
Q4188
|
Amnioarmor, per square centimeter
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.